Sailong Pharmaceutical Group Co., Ltd.
SZSE:002898.SZ
12.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 87.119 | 72.27 | 113.309 | 58.077 | 96.266 | 206.784 | 368.202 | 73.838 | 71.667 | 54.729 | 83.8 |
| Short Term Investments
| 2.144 | -17.521 | -17.891 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 89.262 | 72.27 | 113.309 | 58.077 | 96.266 | 206.784 | 368.202 | 73.838 | 71.667 | 54.729 | 83.8 |
| Net Receivables
| 55.272 | 88.85 | 84.977 | 80.875 | 136.86 | 85.876 | 49.577 | 10.718 | 12.195 | 13.313 | 0 |
| Inventory
| 88.872 | 63.971 | 52.979 | 62.738 | 52.818 | 45.999 | 27.225 | 38.286 | 29.652 | 17.789 | 15.755 |
| Other Current Assets
| 27.194 | 29.266 | 37.875 | 41.201 | 37.084 | 29.867 | 15.627 | 10.3 | 25.513 | 16.674 | 33.637 |
| Total Current Assets
| 256.302 | 254.357 | 289.141 | 242.891 | 323.028 | 368.527 | 460.631 | 134.757 | 139.026 | 102.505 | 133.192 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 352.109 | 394.246 | 405.591 | 408.802 | 379.264 | 247.254 | 178.016 | 111.143 | 63.669 | 33.305 | 32.218 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 112.733 | 104.464 | 103.683 | 98.146 | 94.931 | 60.522 | 51.429 | 47.484 | 48.511 | 49.568 | 3.863 |
| Goodwill and Intangible Assets
| 112.733 | 104.464 | 103.683 | 98.146 | 94.931 | 60.522 | 51.429 | 47.484 | 48.511 | 49.568 | 3.863 |
| Long Term Investments
| 69.856 | 79.803 | 63.08 | 38.664 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 1.96 | 13.559 | 18.568 | 21.565 | 31.087 | 13.922 | 2.245 | 3.002 | 1.002 | 3.376 | 0.828 |
| Other Non-Current Assets
| 20.883 | 1.561 | 2.721 | 3.892 | 7.669 | 65.619 | 22.813 | 9.271 | 12.524 | 0.728 | 16.306 |
| Total Non-Current Assets
| 557.541 | 593.634 | 593.643 | 571.069 | 512.95 | 387.316 | 254.503 | 170.901 | 125.706 | 86.977 | 53.215 |
| Total Assets
| 813.844 | 847.991 | 882.785 | 813.96 | 835.978 | 755.842 | 715.134 | 305.657 | 264.732 | 189.482 | 186.408 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 63.529 | 62.678 | 94.146 | 64.708 | 74.575 | 57.037 | 61.536 | 20.682 | 5.403 | 8.632 | 8.71 |
| Short Term Debt
| 90.048 | 129.691 | 129.871 | 90 | 78.289 | 0 | 15 | 0 | 0 | 10 | 22 |
| Tax Payables
| 4.941 | 10.113 | 5.415 | 1.363 | 6.266 | 10.428 | 5.464 | 16.367 | 18.074 | 13.468 | 14.51 |
| Deferred Revenue
| 37.484 | 23.542 | 32.491 | 30.898 | 17.221 | 12.576 | 14.54 | 5.462 | 10.914 | 21.742 | 23.607 |
| Other Current Liabilities
| 31.009 | 93.968 | 4.652 | 26.435 | -1.381 | 22.836 | -0.343 | 14.162 | 17.143 | -5.008 | 29.218 |
| Total Current Liabilities
| 227.01 | 296.451 | 266.575 | 190.244 | 174.969 | 90.301 | 96.198 | 51.211 | 51.534 | 48.834 | 74.438 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 25.118 | 13.5 | 43.179 | 29.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 2.842 | 3.084 | 3.326 | 3.418 | 1.985 | 2 | 0.3 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 9.76 | 8.607 | 6.043 | 5.035 | 0 | 0 | 0 | 0 | 0 | 0.098 | 0 |
| Other Non-Current Liabilities
| 13.232 | 0.049 | 0 | 1.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 50.952 | 25.191 | 52.548 | 36.713 | 1.985 | 2 | 0.3 | -0 | 0 | 0.098 | 0 |
| Total Liabilities
| 277.962 | 321.642 | 319.124 | 226.957 | 176.954 | 92.301 | 96.498 | 51.211 | 51.534 | 48.932 | 74.438 |
| Equity: | |||||||||||
| Preferred Stock
| 18.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 176 | 176 | 176 | 176 | 160 | 160 | 160 | 120 | 120 | 5 | 0.588 |
| Retained Earnings
| 53.403 | 44.803 | 82.115 | 105.456 | 177.478 | 181.995 | 146.639 | 83.321 | 44.155 | 89.686 | 104.298 |
| Accumulated Other Comprehensive Income/Loss
| 18.01 | 17.077 | 17.077 | 17.077 | 17.077 | 17.077 | 7.528 | 51.125 | 49.043 | -0 | 0 |
| Other Total Stockholders Equity
| 252.45 | 305.547 | 288.469 | 288.469 | 304.469 | 321.546 | 311.997 | 51.125 | 49.043 | 45.865 | 7.084 |
| Total Shareholders Equity
| 535.882 | 526.349 | 563.661 | 587.002 | 659.024 | 663.541 | 618.636 | 254.447 | 213.198 | 140.55 | 111.97 |
| Total Equity
| 535.882 | 526.349 | 563.661 | 587.002 | 659.024 | 663.541 | 618.636 | 254.447 | 213.198 | 140.55 | 111.97 |
| Total Liabilities & Shareholders Equity
| 813.844 | 847.991 | 882.785 | 813.96 | 835.978 | 755.842 | 715.134 | 305.657 | 264.732 | 189.482 | 186.408 |